BD FOCALPOINT? SLIDE PROFILER 490652

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-06-27 for BD FOCALPOINT? SLIDE PROFILER 490652 manufactured by Tripath Imaging, Inc.

Event Text Entries

[48305401] (b)(4). The bd focalpoint? Slide profiler is an automated cervical cytology screening device intended for use in initial screening of cervical cytology slides. The pap test is a screening test for cervical cytology specimens. According to the bethesda system for reporting cytology, while endocervical adenocarcinomas may be directly sampled, the detection of endometrial adenocarcinoma depends on exfoliated cells being present in the collected specimen. Qc review of the 2015 surepath slide shows the presence of 10 to 12 atypical endometrial groups (cannot exclude adenocarcinoma). Bd quality has reviewed the complaint of one false negative, case of endometrial adenocarcinoma that was called? No further review? (nfr) on the focal point. The data provided by the customer was reviewed by bd. Based on the number of slides classified as nfr in july 2015 (n= (b)(4)), it was agreed that the false negative result obtained is within the instrument clinical performance claims. Review of the data also revealed no indication of an instrument mechanical issue during the time frame where the false negative result was obtained. No trend is identified for false negative complaints at this time. Bd will continue to monitor. Device not returned to manufacturer.
Patient Sequence No: 1, Text Type: N, H10


[48305402] Patient slide was processed by the focalpoint as no further review (nfr) on (b)(6) 2015. The case was reported to physician as nfr. Nfr results are treated as a negative result. Patient underwent a endometrial biopsy on (b)(6) 2016 and the cytology pap test was repeated on (b)(6) 2016. The pathologist diagnosis for cytology and histology was endometrial adenocarcinoma. The malignant diagnosis triggered a review of the previous negative slide. The slide was pulled and reviewed manually by two senior cytotechnologists and classified as endometrial adenocarcinoma.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004173866-2016-00001
MDR Report Key5752626
Date Received2016-06-27
Date of Report2016-06-27
Date of Event2015-07-09
Date Mfgr Received2016-05-30
Device Manufacturer Date2009-03-20
Date Added to Maude2016-06-27
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactBDX CAROL NIETO
Manufacturer Street7 LOVETON CIRCLE
Manufacturer CitySPARKS MD 21152
Manufacturer CountryUS
Manufacturer Postal21152
Manufacturer Phone4103164000
Manufacturer G1TRIPATH IMAGING, INC
Manufacturer Street1022 CORPORATE PARK DRIVE
Manufacturer CityMEBANE NC 27302
Manufacturer CountryUS
Manufacturer Postal Code27302
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameBD FOCALPOINT? SLIDE PROFILER
Generic NameFOCAL POINT SLIDE PROFILER
Product CodeMNM
Date Received2016-06-27
Catalog Number490652
Device Availability*
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTRIPATH IMAGING, INC
Manufacturer Address1022 CORPORATE PARK DRIVE MEBANE NC 27302 US 27302


Patients

Patient NumberTreatmentOutcomeDate
101. Life Threatening 2016-06-27

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.